Skip to main content

Table 5 Clinical characteristics of patients grouped as self-reported good asthma control or self-perceived poor control

From: Perception of asthma control among asthmatics seen inChest Clinic at Tertiary Hospital, Addis Ababa, Ethiopia

Variable

 

Self-reported good asthma control (n = 151)

Self-perceived poor asthma control (n = 31)

P value

Adjusted P value

OR

Day time symptom(>2x/wee)

Yes

74(49)

31(100)

0.19

 

1.73(0.69–3.08)

No

77(51)

0(0)

Night awakening

Yes

88(58.3)

30(96.8)

0.003

0.13

5.499(0.59–51.13)

No

63(41.7)

1(3.2)

Use of reliever /SABA >2x/week

Yes

87(57.6)

28(90.3)

0.002

0.076

4.29(0.86–21.45)

No

64(42.4)

3(9.7)

Any Activity limitation

Yes

58(38.4)

24(77.4)

0.000

0.045

3.05 (1.03–9.07)

No

93(61.6)

7 (22.6)

Overall GINA control

Well controlled

80(53)

5(16.1)

0.001

0.87

0.89 (0.21–3.66)

Partly controlled/Uncontrolled

71(47)

26(83.9)

Exacerbation

Yes

74(49)

19(61.3)

0.22

 

1.65 (0.75–3.63)

No

77(51)

12 (38.7)

Incorrect Inhaler Technique

Yes

46(30.9)

16(53.3)

0.02

0.67

1.23 (0.48–3.12)

No

103(69.1)

14(46.7)

Consistent ICS use

Yes

85(56.3)

10(32.3)

0.002

0.02

4.63 (1.73–12.42)

No

66(43.7)

21(67.7)

FVC

≥ 80

44(55.7)

11(64.7)

0.497

 

0.69 (0.23–2.04)

<  80

35(44.3)

6(35.3)

FEV1

≥ 80

19(24.1)

5(29.4)

0.64

 

0.76 (0.24–2.43)

<  80

60(75.9)

12(70.6)

  1. SABA Short acting beta agonist, GINA Global Initiative for Asthma management and prevention, ICS Inhaled corticosteroid, FVC Forced vital capacity, FEV1 Forced Expiratory volume in the first second